Healthcare

Veterinary Point Of Care Diagnostics Market To Grow at CAGR of 12.3% Through 2030

The global Veterinary Point Of Care Diagnostics market size is expected to be worth around US$ 5.69 billion by 2030, according to a new report by Vision Research Reports.

The global Veterinary Point Of Care Diagnostics market size was valued at US$ 2.15 billion in 2020 and is anticipated to grow at a CAGR of 12.3% during forecast period 2021 to 2030.

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/39084

Veterinary Point Of Care Diagnostics Market (By Animal Type: Companion Animals, Livestock Animals; By Product: Consumables, Reagents, & Kits, Instruments & Devices; By Sample Type: Blood/Plasma/Serum, Urine, Fecal; By Testing: Hematology, Diagnostic Imaging, Bacteriology, Virology, Cytology, Clinical Chemistry, Parasitology, Serology; By Indication: Infectious Disease, General Ailments; By End-use: Veterinary Hospitals & Clinics, Home Care Settings) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Report Coverage

Report Scope Details
Market Size US$ 5.69 billion by 2030
Growth Rate CAGR of 12.3% From 2021 to 2030
Largest Market North America
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Animal Type, Product, Sample type, Testing category, Indication, End use

Growth Factors

Technological advancements, strategic initiatives by key market players, rising pet population and humanization, the need to reduce antimicrobial resistance, and the expansion of service offerings by vet clinics are key factors driving the market. Heska, for instance, allocates its R&D budget for developing new Analyzer and Diagnostics Platforms, expanding the menu of analyzer platforms, upgrading the cycle to already installed platforms, and other in-house inventions. The market witnessed a slowdown in sales, reduced demand, and logistical challenges due to the COVID-19 pandemic. The uncertainty was exacerbated by the changing lockdown measures, guidelines on the movement of people and goods, remote work, and self-quarantine conditions.

Several key animal health companies also registered increased profits during 2020. This was owing to the deployment of various strategic initiatives such as diverting their resources to profitable segments to ensure business continuity, acquisitions, and the launch of new products. Heska, for instance, reported 97.4% of growth in its revenue during the first quarter of 2021. IDEXX Laboratories, Inc. reported a 12% increase in year-on-year revenue, driven by the Companion Animal Group (CAG) diagnostics segment, during 2020.

Key Players

  • IDEXX Laboratories
  • Zoetis
  • Virbac
  • Heska Corporation
  • Thermo Fisher Scientific, Inc.
  • Neogen Corporation
  • Mindray
  • Esaote SpA
  • FUJIFILM Corporation
  • Woodley Equipment Company Ltd.

Market Segmentation

  • By Animal Type
    • Companion Animals
      • Dogs
      • Cats
      • Horses
      • Others
    • Livestock Animals
      • Cattle
      • Swine
      • Poultry
      • Others
  • By Product
    • Consumables, Reagents, & Kits
    • Instruments & Devices
  • By Sample Type
    • Blood/Plasma/Serum
    • Urine
    • Fecal
    • Others
  • By Testing Category
    • Hematology
    • Diagnostic Imaging
    • Bacteriology
    • Virology
    • Cytology
    • Clinical Chemistry
    • Parasitology
    • Serology
    • Others
  • By Indication
    • Infectious Disease
    • General Ailments
    • Others
  • By End-use
    • Veterinary Hospitals & Clinics
    • Home Care Settings
    • Others
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • MEA
      • South Africa
      • Saudi Arabia
      • Israel

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39084

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Veterinary Point Of Care Diagnostics Market, By Animal Type

7.1.  Veterinary Point Of Care Diagnostics Market, by Animal Type, 2021-2030

7.1.1.    Companion Animals

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Livestock Animals

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Veterinary Point Of Care Diagnostics Market, By Product

8.1.  Veterinary Point Of Care Diagnostics Market, by Product, 2021-2030

8.1.1.    Consumables, Reagents, & Kits

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Instruments & Devices

8.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Veterinary Point Of Care Diagnostics Market, By Sample Type

9.1.  Veterinary Point Of Care Diagnostics Market, by Sample Type, 2021-2030

9.1.1.    Blood/Plasma/Serum

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Urine

9.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Veterinary Point Of Care Diagnostics Market, By Testing Category

10.1.        Veterinary Point Of Care Diagnostics Market, by Testing Category, 2021-2030

10.1.1.  Hematology

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Diagnostic Imaging

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Bacteriology

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Virology

10.1.4.1.      Market Revenue and Forecast (2017-2030)

10.1.5.  Cytology

10.1.5.1.      Market Revenue and Forecast (2017-2030)

10.1.6.  Virology

10.1.6.1.      Market Revenue and Forecast (2017-2030)

10.1.7.  Clinical Chemistry

10.1.7.1.      Market Revenue and Forecast (2017-2030)

10.1.8.  Parasitology

10.1.8.1.      Market Revenue and Forecast (2017-2030)

10.1.9.  Serology

10.1.9.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global Veterinary Point Of Care Diagnostics Market, By Indication

11.1.        Veterinary Point Of Care Diagnostics Market, by Indication, 2021-2030

11.1.1.  Infectious Disease

11.1.1.1.      Market Revenue and Forecast (2017-2030)

11.1.2.  General Ailments

11.1.2.1.      Market Revenue and Forecast (2017-2030)

Chapter 12.      Global Veterinary Point Of Care Diagnostics Market, By End-use

12.1.        Veterinary Point Of Care Diagnostics Market, by End-use, 2021-2030

12.1.1.  Veterinary Hospitals & Clinics

12.1.1.1.      Market Revenue and Forecast (2017-2030)

12.1.2.  Home Care Settings

12.1.2.1.      Market Revenue and Forecast (2017-2030)

Chapter 13.      Global Veterinary Point Of Care Diagnostics  Market, Regional Estimates and Trend Forecast

13.1.        North America

13.1.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

13.1.2.  Market Revenue and Forecast, by Product (2017-2030)

13.1.3.  Market Revenue and Forecast, by Sample Type (2017-2030)

13.1.4.  Market Revenue and Forecast, by Testing Category (2017-2030)

13.1.5.  Market Revenue and Forecast, by Indication (2017-2030)

13.1.6.  Market Revenue and Forecast, by End-use (2017-2030)

13.1.7.  U.S.

13.1.7.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.1.7.2.      Market Revenue and Forecast, by Product (2017-2030)

13.1.7.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.1.7.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.1.7.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.1.7.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.1.8.  Rest of North America

13.1.8.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.1.8.2.      Market Revenue and Forecast, by Product (2017-2030)

13.1.8.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.1.8.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.1.8.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.1.8.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.2.        Europe

13.2.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

13.2.2.  Market Revenue and Forecast, by Product (2017-2030)

13.2.3.  Market Revenue and Forecast, by Sample Type (2017-2030)

13.2.4.  Market Revenue and Forecast, by Testing Category (2017-2030)

13.2.5.  Market Revenue and Forecast, by Indication (2017-2030)

13.2.6.  Market Revenue and Forecast, by End-use (2017-2030)

13.2.7.  UK

13.2.7.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.2.7.2.      Market Revenue and Forecast, by Product (2017-2030)

13.2.7.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.2.7.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.2.7.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.2.7.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.2.8.  Germany

13.2.8.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.2.8.2.      Market Revenue and Forecast, by Product (2017-2030)

13.2.8.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.2.8.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.2.8.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.2.8.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.2.9.  France

13.2.9.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.2.9.2.      Market Revenue and Forecast, by Product (2017-2030)

13.2.9.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.2.9.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.2.9.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.2.9.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.2.10.               Rest of Europe

13.2.10.1.   Market Revenue and Forecast, by Animal Type (2017-2030)

13.2.10.2.   Market Revenue and Forecast, by Product (2017-2030)

13.2.10.3.   Market Revenue and Forecast, by Sample Type (2017-2030)

13.2.10.4.   Market Revenue and Forecast, by Testing Category (2017-2030)

13.2.10.5.   Market Revenue and Forecast, by Indication (2017-2030)

13.2.10.6.   Market Revenue and Forecast, by End-use (2017-2030)

13.3.        APAC

13.3.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

13.3.2.  Market Revenue and Forecast, by Product (2017-2030)

13.3.3.  Market Revenue and Forecast, by Sample Type (2017-2030)

13.3.4.  Market Revenue and Forecast, by Testing Category (2017-2030)

13.3.5.  Market Revenue and Forecast, by Indication (2017-2030)

13.3.6.  Market Revenue and Forecast, by End-use (2017-2030)

13.3.7.  India

13.3.7.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.3.7.2.      Market Revenue and Forecast, by Product (2017-2030)

13.3.7.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.3.7.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.3.7.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.3.7.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.3.8.  China

13.3.8.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.3.8.2.      Market Revenue and Forecast, by Product (2017-2030)

13.3.8.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.3.8.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.3.8.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.3.8.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.3.9.  Japan

13.3.9.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.3.9.2.      Market Revenue and Forecast, by Product (2017-2030)

13.3.9.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.3.9.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.3.9.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.3.9.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.3.10.               Rest of APAC

13.3.10.1.   Market Revenue and Forecast, by Animal Type (2017-2030)

13.3.10.2.   Market Revenue and Forecast, by Product (2017-2030)

13.3.10.3.   Market Revenue and Forecast, by Sample Type (2017-2030)

13.3.10.4.   Market Revenue and Forecast, by Testing Category (2017-2030)

13.3.10.5.   Market Revenue and Forecast, by Indication (2017-2030)

13.3.10.6.   Market Revenue and Forecast, by End-use (2017-2030)

13.4.        MEA

13.4.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

13.4.2.  Market Revenue and Forecast, by Product (2017-2030)

13.4.3.  Market Revenue and Forecast, by Sample Type (2017-2030)

13.4.4.  Market Revenue and Forecast, by Testing Category (2017-2030)

13.4.5.  Market Revenue and Forecast, by Indication (2017-2030)

13.4.6.  Market Revenue and Forecast, by End-use (2017-2030)

13.4.7.  GCC

13.4.7.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.4.7.2.      Market Revenue and Forecast, by Product (2017-2030)

13.4.7.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.4.7.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.4.7.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.4.7.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.4.8.  North Africa

13.4.8.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.4.8.2.      Market Revenue and Forecast, by Product (2017-2030)

13.4.8.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.4.8.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.4.8.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.4.8.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.4.9.  South Africa

13.4.9.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.4.9.2.      Market Revenue and Forecast, by Product (2017-2030)

13.4.9.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.4.9.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.4.9.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.4.9.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.4.10.               Rest of MEA

13.4.10.1.   Market Revenue and Forecast, by Animal Type (2017-2030)

13.4.10.2.   Market Revenue and Forecast, by Product (2017-2030)

13.4.10.3.   Market Revenue and Forecast, by Sample Type (2017-2030)

13.4.10.4.   Market Revenue and Forecast, by Testing Category (2017-2030)

13.4.10.5.   Market Revenue and Forecast, by Indication (2017-2030)

13.4.10.6.   Market Revenue and Forecast, by End-use (2017-2030)

13.5.        Latin America

13.5.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

13.5.2.  Market Revenue and Forecast, by Product (2017-2030)

13.5.3.  Market Revenue and Forecast, by Sample Type (2017-2030)

13.5.4.  Market Revenue and Forecast, by Testing Category (2017-2030)

13.5.5.  Market Revenue and Forecast, by Indication (2017-2030)

13.5.6.  Market Revenue and Forecast, by End-use (2017-2030)

13.5.7.  Brazil

13.5.7.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.5.7.2.      Market Revenue and Forecast, by Product (2017-2030)

13.5.7.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.5.7.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.5.7.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.5.7.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.5.8.  Rest of LATAM

13.5.8.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.5.8.2.      Market Revenue and Forecast, by Product (2017-2030)

13.5.8.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.5.8.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.5.8.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.5.8.6.      Market Revenue and Forecast, by End-use (2017-2030)

Chapter 14.  Company Profiles

14.1.              IDEXX Laboratories

14.1.1.  Company Overview

14.1.2.  Product Offerings

14.1.3.  Financial Performance

14.1.4.  Recent Initiatives

14.2.              Zoetis

14.2.1.  Company Overview

14.2.2.  Product Offerings

14.2.3.  Financial Performance

14.2.4.  Recent Initiatives

14.3.              Virbac

14.3.1.  Company Overview

14.3.2.  Product Offerings

14.3.3.  Financial Performance

14.3.4.  Recent Initiatives

14.4.              Heska Corporation

14.4.1.  Company Overview

14.4.2.  Product Offerings

14.4.3.  Financial Performance

14.4.4.  Recent Initiatives

14.5.              Thermo Fisher Scientific, Inc.

14.5.1.  Company Overview

14.5.2.  Product Offerings

14.5.3.  Financial Performance

14.5.4.  Recent Initiatives

14.6.              Neogen Corporation

14.6.1.  Company Overview

14.6.2.  Product Offerings

14.6.3.  Financial Performance

14.6.4.  Recent Initiatives

14.7.              Mindray

14.7.1.  Company Overview

14.7.2.  Product Offerings

14.7.3.  Financial Performance

14.7.4.  Recent Initiatives

14.8.              Esaote SpA

14.8.1.  Company Overview

14.8.2.  Product Offerings

14.8.3.  Financial Performance

14.8.4.  Recent Initiatives

14.9.              FUJIFILM Corporation

14.9.1.  Company Overview

14.9.2.  Product Offerings

14.9.3.  Financial Performance

14.9.4.  Recent Initiatives

14.10.           Woodley Equipment Company Ltd.

14.10.1.               Company Overview

14.10.2.               Product Offerings

14.10.3.               Financial Performance

14.10.4.               Recent Initiatives

Chapter 15.  Research Methodology

15.1.              Primary Research

15.2.              Secondary Research

15.3.              Assumptions

Chapter 16.  Appendix

16.1.              About Us

16.2.              Glossary of Terms

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39084

About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.

Contact Us:

call: +1 9197 992 333

Vision Research Report

Any Assistance, Email – sales@visionresearchreports.com

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button